Greater scrutiny of financial ties to clinical investigators coupled with increased accountability and drug safety puts more pressure on contracting executives to clearly outline responsibilities from the start.
Attend Clinical Trial Cost & Contract Management West this November 9-10 and take back to the office the necessary tools to streamline processes and better define accountability and responsibilities:
∙ Gain the upper hand in your contract with a workshop dedicated to contract approach and development
∙ Avoid embarrassing and costly violations regarding financial ties to clinical investigators with a firm grasp on Fair Market Value (FMV)
∙ Bring your drug to market before your competitors by fine tuning your strategy for handling Intellectual Property (IP)
∙ Improve the quality of you’re 3rd party clinical research data with warning signals and outline methods direct from an FDA representative
∙ Improve ROI by defining best practices for handling site payment disputes with your CRO
To view the full agenda click here!
Visit the website here to place your registration.
Search This Blog
Blog Archive
-
▼
2009
(141)
-
▼
August
(12)
- Outsourcing of clinical trials expected to rise by...
- Pfizer to create online networking site for clinic...
- Medicare's Stance on Clinical Trials
- Stem cells for the heart in clinical trial
- Biopharma in India is Surging
- goBalto, Matchmaking for CROs and Drug Developers
- India Expected to Take Larger Share of Outsourcin...
- Clinical Trial Cost & Contract Management Agenda F...
- Web Seminar: REMS, EU-RMP and FDAAA: Navigating th...
- Repros Therapeutics Inc. halts clinical trial
- Outsourcing to grow 10% says WSHP
- USA and Europe team together to monitor clinical t...
-
▼
August
(12)
No comments:
Post a Comment